Skip to content

Endourological Management of Stones During COVID19

Definitive Endourological Interventions for Urolithiasis Management During COVID19- Outcomes From a Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05293262
Enrollment
158
Registered
2022-03-24
Start date
2020-01-23
Completion date
2020-08-31
Last updated
2022-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Urolithiasis

Keywords

endourology, pandemic

Brief summary

Guidelines for endourological procedures during COVID-19 have suggested deferring all elective procedures, while obstructed/ infected stones should undergo urgent decompression. At our centre, screening protocols were implemented with prioritization strategies so that elective care could safely continue at deescalated rates. COVID or septic patients underwent emergency decompression, while non-COVID and non-septic patients underwent primary ureteroscopy (URS) or retrograde intrarenal surgery (RIRS). We aim to report our experience with endourological surgery for stone disease during COVID-19.

Detailed description

We conducted a retrospective review of a prospectively maintained database of all endourological surgeries for stones in our centre during the first wave of COVID19.

Interventions

PROCEDUREEndourological surgery

Includes ureteral stent insertion, ureteroscopies and retrograde intrarenal surgeies

Sponsors

Roxanne Teo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- all patient with urolithiasis who underwent endourological interventions during COVID19 pandemic

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stayFrom admission to discharge from hospital, up to 3 monthsLength of hospital stay
Complication rateFrom admission up to 3 months post operativelyComplications as defined by Clavien Dindo classification system
Stone free rateAt follow up visit in clinic 3 months post procedure

Secondary

MeasureTime frame
Readmission rateFrom discharge up to three months post operatively

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026